Changes of dopamine content and cell proliferation by dexamethsone via pituitary adenylate cyclase-activating polypeptide in PC12 cell

Ting Ting Yang, Chiung Wen Tsao, Jin Shiou Li, Hung Tsung Wu, Chao Tien Hsu, Juei Tang Cheng

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) is an endogenous neuropeptide observed in adrenal gland and sympathetic ganglia to regulate catecholamine synthesis and release. Both PACAP and glucocorticoid showed the activity to elevate catecholamine level through the stimulation of biosynthesis. However, the relationship of glucocorticoid and PACAP for this action is still unclear. Thus, alterations of gene expression, dopamine (DA) content, and cell proliferation in rat pheochromocytoma PC12 cells are employed as indicators to clarify this relationship in the present study. From the analysis of RT-PCR, the mRNA level of PACAP was observed to be raised by dexamethasone (DEX) and this action was blocked in cells treated with RU486 (mifepristone), a glucocorticoid receptor (GR) antagonist, or actinomycin D, a transcriptional inhibitor. An increase of DA content by HPLC analysis and/or cell proliferation identified by MTT assay by DEX was also observed which could be inhibited by PACAP (6-38) at concentration sufficient to block PACAP type 1 (PAC1) receptor. These results suggest that PACAP is involved in DEX-induced DA biosynthesis and cell proliferation in PC12 cells.

Original languageEnglish
Pages (from-to)45-48
Number of pages4
JournalNeuroscience Letters
Volume426
Issue number1
DOIs
Publication statusPublished - Oct 9 2007
Externally publishedYes

Fingerprint

Pituitary Adenylate Cyclase-Activating Polypeptide
PC12 Cells
Dopamine
Cell Proliferation
Dexamethasone
Glucocorticoids
Catecholamines
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
Mifepristone
Sympathetic Ganglia
Glucocorticoid Receptors
Dactinomycin
Pheochromocytoma
Adrenal Glands
Neuropeptides
High Pressure Liquid Chromatography
Gene Expression
Polymerase Chain Reaction
Messenger RNA

Keywords

  • Cell proliferation
  • Dexamethasone
  • Dopamine content
  • PC12 cell
  • Pituitary adenylate cyclase-activating polypeptide (PACAP)

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Changes of dopamine content and cell proliferation by dexamethsone via pituitary adenylate cyclase-activating polypeptide in PC12 cell. / Yang, Ting Ting; Tsao, Chiung Wen; Li, Jin Shiou; Wu, Hung Tsung; Hsu, Chao Tien; Cheng, Juei Tang.

In: Neuroscience Letters, Vol. 426, No. 1, 09.10.2007, p. 45-48.

Research output: Contribution to journalArticle

Yang, Ting Ting ; Tsao, Chiung Wen ; Li, Jin Shiou ; Wu, Hung Tsung ; Hsu, Chao Tien ; Cheng, Juei Tang. / Changes of dopamine content and cell proliferation by dexamethsone via pituitary adenylate cyclase-activating polypeptide in PC12 cell. In: Neuroscience Letters. 2007 ; Vol. 426, No. 1. pp. 45-48.
@article{da580fcc1a894d16a4b5a4de06432a34,
title = "Changes of dopamine content and cell proliferation by dexamethsone via pituitary adenylate cyclase-activating polypeptide in PC12 cell",
abstract = "Pituitary adenylate cyclase-activating polypeptide (PACAP) is an endogenous neuropeptide observed in adrenal gland and sympathetic ganglia to regulate catecholamine synthesis and release. Both PACAP and glucocorticoid showed the activity to elevate catecholamine level through the stimulation of biosynthesis. However, the relationship of glucocorticoid and PACAP for this action is still unclear. Thus, alterations of gene expression, dopamine (DA) content, and cell proliferation in rat pheochromocytoma PC12 cells are employed as indicators to clarify this relationship in the present study. From the analysis of RT-PCR, the mRNA level of PACAP was observed to be raised by dexamethasone (DEX) and this action was blocked in cells treated with RU486 (mifepristone), a glucocorticoid receptor (GR) antagonist, or actinomycin D, a transcriptional inhibitor. An increase of DA content by HPLC analysis and/or cell proliferation identified by MTT assay by DEX was also observed which could be inhibited by PACAP (6-38) at concentration sufficient to block PACAP type 1 (PAC1) receptor. These results suggest that PACAP is involved in DEX-induced DA biosynthesis and cell proliferation in PC12 cells.",
keywords = "Cell proliferation, Dexamethasone, Dopamine content, PC12 cell, Pituitary adenylate cyclase-activating polypeptide (PACAP)",
author = "Yang, {Ting Ting} and Tsao, {Chiung Wen} and Li, {Jin Shiou} and Wu, {Hung Tsung} and Hsu, {Chao Tien} and Cheng, {Juei Tang}",
year = "2007",
month = "10",
day = "9",
doi = "10.1016/j.neulet.2007.08.037",
language = "English",
volume = "426",
pages = "45--48",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Changes of dopamine content and cell proliferation by dexamethsone via pituitary adenylate cyclase-activating polypeptide in PC12 cell

AU - Yang, Ting Ting

AU - Tsao, Chiung Wen

AU - Li, Jin Shiou

AU - Wu, Hung Tsung

AU - Hsu, Chao Tien

AU - Cheng, Juei Tang

PY - 2007/10/9

Y1 - 2007/10/9

N2 - Pituitary adenylate cyclase-activating polypeptide (PACAP) is an endogenous neuropeptide observed in adrenal gland and sympathetic ganglia to regulate catecholamine synthesis and release. Both PACAP and glucocorticoid showed the activity to elevate catecholamine level through the stimulation of biosynthesis. However, the relationship of glucocorticoid and PACAP for this action is still unclear. Thus, alterations of gene expression, dopamine (DA) content, and cell proliferation in rat pheochromocytoma PC12 cells are employed as indicators to clarify this relationship in the present study. From the analysis of RT-PCR, the mRNA level of PACAP was observed to be raised by dexamethasone (DEX) and this action was blocked in cells treated with RU486 (mifepristone), a glucocorticoid receptor (GR) antagonist, or actinomycin D, a transcriptional inhibitor. An increase of DA content by HPLC analysis and/or cell proliferation identified by MTT assay by DEX was also observed which could be inhibited by PACAP (6-38) at concentration sufficient to block PACAP type 1 (PAC1) receptor. These results suggest that PACAP is involved in DEX-induced DA biosynthesis and cell proliferation in PC12 cells.

AB - Pituitary adenylate cyclase-activating polypeptide (PACAP) is an endogenous neuropeptide observed in adrenal gland and sympathetic ganglia to regulate catecholamine synthesis and release. Both PACAP and glucocorticoid showed the activity to elevate catecholamine level through the stimulation of biosynthesis. However, the relationship of glucocorticoid and PACAP for this action is still unclear. Thus, alterations of gene expression, dopamine (DA) content, and cell proliferation in rat pheochromocytoma PC12 cells are employed as indicators to clarify this relationship in the present study. From the analysis of RT-PCR, the mRNA level of PACAP was observed to be raised by dexamethasone (DEX) and this action was blocked in cells treated with RU486 (mifepristone), a glucocorticoid receptor (GR) antagonist, or actinomycin D, a transcriptional inhibitor. An increase of DA content by HPLC analysis and/or cell proliferation identified by MTT assay by DEX was also observed which could be inhibited by PACAP (6-38) at concentration sufficient to block PACAP type 1 (PAC1) receptor. These results suggest that PACAP is involved in DEX-induced DA biosynthesis and cell proliferation in PC12 cells.

KW - Cell proliferation

KW - Dexamethasone

KW - Dopamine content

KW - PC12 cell

KW - Pituitary adenylate cyclase-activating polypeptide (PACAP)

UR - http://www.scopus.com/inward/record.url?scp=34548829898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548829898&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2007.08.037

DO - 10.1016/j.neulet.2007.08.037

M3 - Article

VL - 426

SP - 45

EP - 48

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1

ER -